Treatment of Leishmania donovani infections with surface-active agents.
D006801:Humans; D007893:Leishmania donovani; D007896:Leishmaniasis; D013501:Surface-Active Agents / Q000494:pharmacology*
D013501:Surface-Active Agents
LEISHMANIASIS; SURFACE-ACTIVE AGENTS/pharmacology